BRIEF-Aldeyra announcesd new data for ADX-102 from Phase 2 clinical trials
October 10, 2017 at 07:42 AM EDT
* Aldeyra - announced new clinical data for ADX-102 from recently completed Phase 2 clinical trials of dry eye disease and allergic conjunctivitis